The first weeks on a GLP-1 usually mean a low starting dose that your prescriber raises gradually, a quieter appetite, and for many people mild to moderate digestive side effects. Knowing what is common and what to report makes the start easier.
The first weeks on a GLP-1 medication are mostly about getting used to it. Treatment starts at a low dose that your prescriber increases step by step, because digestive side effects such as nausea are common and tend to cluster during these increases. Many people notice that they feel full sooner and think about food less. Weight changes build gradually over months rather than weeks, and knowing which symptoms are expected and which need a call to your provider makes the start smoother.
Both the Wegovy and Zepbound labels use a stepwise escalation: a starting dose for the first weeks, then increases at set intervals until the prescriber reaches a maintenance dose that works for the patient. This gradual approach matters for tolerability. The Zepbound label states that most nausea, vomiting and diarrhea events occurred during dose escalation and decreased over time. The pivotal SURMOUNT-1 trial, published in the New England Journal of Medicine in 2022, told a similar story: the most common adverse events with tirzepatide were gastrointestinal, mostly mild to moderate, and occurred primarily during dose escalation.
This article does not include a schedule, because dosing is individualized and set by the prescriber. If a step feels too hard, tell your provider rather than adjusting on your own. They may hold or change the plan.
Reduced appetite is a core part of how these medications work. In a 2017 crossover study of 30 adults with obesity, published in Diabetes, Obesity and Metabolism, 12 weeks of semaglutide lowered total energy intake across self-selected meals by about 24 percent compared with placebo, with less hunger and fewer food cravings. A smaller appetite can be a welcome change, but clinical guidance notes it also calls for monitoring to make sure nutrient and fluid intake stay adequate. For background, see How GLP-1 Medications Work.
The Wegovy label gives a clear sense of how common these are over the full treatment period at its highest dose, compared with placebo:
| Side effect | Wegovy | Placebo |
|---|---|---|
| Nausea | 44 percent | 16 percent |
| Diarrhea | 30 percent | 16 percent |
| Vomiting | 24 percent | 6 percent |
| Constipation | 24 percent | 11 percent |
| Abdominal pain | 20 percent | 10 percent |
The Zepbound label lists nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, injection site reactions, fatigue, burping, hair loss and acid reflux among its most common adverse reactions. For practical strategies, see Common GLP-1 Side Effects and How People Manage Them.
According to NIDDK, adults who take weight management medications as part of a lifestyle program reduce their weight by an average of 3 to 12 percent more of their starting weight after a year than people who do not take medication, and most of the change happens within the first 6 months. NIDDK also notes that if someone does not reach at least a 5 percent reduction after 12 weeks on the full dose, their health care professional will probably advise stopping. These are averages from many people; your own pattern may differ.
A 2024 review in the journal Obesity on nutrition with anti-obesity medications recommends that clinicians counsel patients on protein, dietary fiber, micronutrients and fluids, and monitor for gastrointestinal symptoms or inadequate intake during treatment. In everyday terms:
NIDDK and the labels highlight several points worth raising at the start:
The labels and the FDA describe several symptoms that should not wait for your next routine check-in:
If your medication comes in a vial, confirm exactly how much to draw up and in which units. The FDA has received reports of dosing errors, some requiring hospitalization, when patients measured and self-administered incorrect amounts of compounded GLP-1 drugs. Compounded products are not FDA-approved, and the agency does not review them for safety, effectiveness or quality before they are sold.
Nausea is the most common side effect. In the Wegovy label it was reported by 44 percent of participants on the highest dose versus 16 percent on placebo, and the Zepbound label notes most events occurred during dose escalation and decreased over time. Tell your provider if it is severe, persistent or keeps you from eating and drinking.
It varies. Weight change with these medications builds over months, and NIDDK notes that most of it happens within the first 6 months. Early weeks at a low dose are mainly about tolerating the medication.
Follow the instructions your prescriber gave you. The labels give specific missed-dose rules that depend on how much time has passed, and missing several doses in a row can mean restarting at a lower dose. Do not double up.
Your appetite will likely be smaller, so the quality of each meal matters more. Clinical guidance emphasizes enough protein, fiber, micronutrients and fluids, and staying active, while appetite is reduced.
A good start depends on a clear plan: who to contact with questions, which symptoms to report, and how progress will be judged. A licensed provider can review your health history and medications and adjust the plan as you go. This article is educational and does not determine eligibility for any treatment.
Written by the NewDay Wellness editorial team from the sources above and checked against them before publication, and medically reviewed by Dr. Sean Arora and Dr. Shannon Arora of Arora Health & Aesthetics; see our editorial standards. This article is educational and does not diagnose conditions, establish eligibility for any medication, or replace care from a licensed provider. Compounded medications are not FDA-approved.
When appetite drops, the quality of each meal matters more. A practical guide to protein, fiber, fluids and micronutrients while taking a GLP-1 medication, drawn from published clinical guidance.
Read articleNausea, constipation, fatigue and other frequent side effects of GLP-1 medications, what the trial data say about how common they are, and practical strategies people use with their provider's guidance.
Read article
You can travel, celebrate and eat out on a GLP-1 medication with some planning: keep medication in your carry-on and follow your pharmacy's storage instructions, order smaller portions, keep fluids up, and ask your prescriber how to handle timing changes.
Read article